Evidence map›Paper›PMID 37372912›Full record

ReviewHealthcare (Basel, Switzerland)2023

What Do We Know about Nociplastic Pain?

Kacper Bułdyś, Tomasz Górnicki, Dariusz Kałka, Ewa Szuster, Małgorzata Biernikiewicz, Leszek Markuszewski, Małgorzata Sobieszczańska

Registry-linked trialAbstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07125781 (Prevalence of Central Sensitization and Nociplastic Pain in Individuals Diagnosed With Pes Planus), which is not on this map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07125781 completednot on this mapstarted 2024, after this paper: background citation

Prevalence of Central Sensitization and Nociplastic Pain in Individuals Diagnosed With Pes Planus: A Multicenter Cross-Sectional Study

TypeobservationalSponsorBozok UniversityRan2024 to 2025Enrolled214ConditionsPes Planus, Flatfoot, Central Sensitization, Nociplastic Pain
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kacper BułdyśFaculty of Medical Sciences and Health Sciences, Kazimierz Pulaski University of Technology and Humanities in Radom, 26-600 Radom, Poland.ORCID 0000-0003-4933-9198
Tomasz GórnickiFaculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.ORCID 0000-0002-7277-8036
Dariusz KałkaFaculty of Physiotherapy, Wroclaw University of Health and Sport Sciences, 51-612 Wroclaw, Poland.ORCID 0000-0002-5024-3903
Ewa SzusterCardiosexology Students Club, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0003-1154-1606
Małgorzata BiernikiewiczMen's Health Centre in Wrocław, 53-151 Wroclaw, Poland.ORCID 0000-0003-2377-5290
Leszek MarkuszewskiFaculty of Medical Sciences and Health Sciences, Kazimierz Pulaski University of Technology and Humanities in Radom, 26-600 Radom, Poland.
Małgorzata SobieszczańskaClinical Department of Geriatrics, Wroclaw Medical University, 50-369 Wroclaw, Poland.ORCID 0000-0003-4374-9866

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nociplastic pain is a recently distinguished type of pain, distinct from neuropathic and nociceptive pain, and is well described in the literature. It is often mistaken for central sensitization. Pathophysiology has not been clearly established with regard to alteration of the concentration of spinal fluid elements, the structure of the white and gray matter of the brain, and psychological aspects. Many different diagnostic tools, i.e., the painDETECT and Douleur Neuropathique 4 questionnaires, have been developed to diagnose neuropathic pain, but they can also be applied for nociplastic pain; however, more standardized instruments are still needed in order to assess its occurrence and clinical presentation. Numerous studies have shown that nociplastic pain is present in many different diseases such as fibromyalgia, complex regional pain syndrome type 1, and irritable bowel syndrome. Current pharmacological and nonpharmacological treatments for nociceptive and neuropathic pain are not entirely suitable for treating nociplastic pain. There is an ongoing effort to establish the most efficient way to manage it. The significance of this field has led to several clinical trials being carried out in a short time. The aim of this narrative review was to discuss the currently available evidence on pathophysiology, associated diseases, treatment possibilities, and clinical trials. It is important that physicians widely discuss and acknowledge this relatively new concept in order to provide optimized pain control for patients.

Indexed as

chronic paindiagnosismanagementnociplastic pain

Identifiers

PMID37372912
PMCPMC10298569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.